HomeAKRO • NASDAQ
add
Akero Therapeutics Inc
Nakaraang pagsara
$31.16
Sakop ng araw
$30.76 - $31.65
Sakop ng taon
$15.32 - $37.00
Market cap
2.31B USD
Average na Volume
623.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 81.70M | 75.27% |
Net na kita | -72.70M | -83.33% |
Net profit margin | — | — |
Kita sa bawat share | -1.05 | -47.89% |
EBITDA | -81.70M | -75.29% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 717.25M | 29.30% |
Kabuuang asset | 817.55M | 28.68% |
Kabuuang sagutin | 79.22M | 51.78% |
Kabuuang equity | 738.32M | — |
Natitirang share | 69.80M | — |
Presyo para makapag-book | 2.94 | — |
Return on assets | -24.28% | — |
Return on capital | -25.40% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -72.70M | -83.33% |
Cash mula sa mga operasyon | -70.42M | -41.64% |
Cash mula sa pag-invest | 73.07M | 158.13% |
Cash mula sa financing | 3.07M | 280.52% |
Net change in cash | 5.71M | 103.27% |
Malayang cash flow | -45.93M | -25.63% |
Tungkol
Itinatag
2017
Headquarters
Website
Mga Empleyado
60
